Development of autoantibodies and factor VIII inhibitor in an HIV- infected haemophiliac following treatment with combination anti-retroviral therapy [3]

British Journal of Haematology

Volumn 102, Issue 5, 1998, Pages 1382-1383

  Evans, G D ^a   Mendelson, G M S ^a   Lever, A M L ^a   Baglin, T P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Haemophilia; HIV infected haemophiliacs; Protease inhibitors

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIRETROVIRUS AGENT; BLOOD CLOTTING FACTOR 8; INDINAVIR; LAMIVUDINE;

ADOLESCENT; ANTIBODY PRODUCTION; AUTOIMMUNITY; BLEEDING; BLOOD COMPONENT THERAPY; CASE REPORT; HEMOPHILIA; HEMOPHILIA A; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS COMPLICATION; LETTER; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0031717406     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00984.x     Document Type: Letter

References (6)

1. 1 Bertina, R.M, Koeleman, B.P.C, Koster, T, Rosendaal, F.R, Dirven, R.J, de Ronde, H, van der Velden, P.A, Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64 67.
2. 2 Cox, M.J, Rees, D.C, Martinson, J.J, Clegg, J.B. (1996) Evidence for a single origin of factor V Leiden. British Journal of Haematology, 92, 1022 1026.
3. 3 Rees, D.C. (1996) The population genetics of factor V Leiden (Arg506Gln). British Journal of Haematology, 95, 579 586.
4. 4 Rees, D.C, Cox, M, Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133 1134.
5. 5 Zivelin, A, Griffin, J, Xu, X, Pabinger, I, Samama, M, Conrad, J, Brenner, B, Eldor, A, Seligsohn, U. (1997) A single genetic origin for a common risk factor for venous thrombosis. Blood, 89, 397 402.
6. 6 Zoller, B, Hillarp, A, Dahlback, B. (1997) Activated protein C resistance caused by a common factor V mutation has a single origin. Thrombosis Research, 85, 237 243.